|
Media Releases |
Financial Reports |
Presen-tations |
|
10/18/1999
|
|
|
|
| The today's Extraordinary Shareholders' Meeting of Alusuisse Lonza Group Ltd chaired by Mr Martin Ebner was attended by 847 shareholders who represented 55% of the votes and the capital. |
Zurich, 18 October 1999 - The shareholders approved with clear majority all proposals of the Board of Directors. Thus the chemicals and energy activities will be demerged into Lonza Group Ltd. At the same time a prerequisite for the implementation of the three-way merger of algroup with Alcan and Pechiney was met.
The new Lonza Group Ltd
Lonza Group Ltd will be a worldwide leader in the production of exclusive fine chemicals for the life science industry, with a strong foothold in biotech processes and an excellent growth portfolio in organic fine chemicals, intermediates and additives.
In 1998 Lonza Group had a global workforce of 5651 employees. Lonza has 20 manufacturing facilities in 8 countries and 22 sales companies serving customers in more than 90 countries. Net sales for 1998 amounted to CHF 2153 million, operating income to CHF 292 million. Earnings before interest, taxes and depreciation (EBITDA) were CHF 464 million and proforma net income CHF 213 million.
The first day of trading of the new Swiss company's shares on SWX Swiss Exchange will be 1 November 1999.
Mr Martin Ebner will be Chairman of the Board of Directors of the new company, Mr Christoph Blocher Vice Chairman, Mr Sergio Marchionne Managing Director, Mr Rupert Gasser and Mr Peter Kalantzis members. The Chief Executive Officer of the new Lonza Group Ltd with headquarters in Zurich will be Mr Sergio Marchionne.
Further information:
Corporate Communications
t +41 1 385 24 95
f +41 1 386 24 90
|
|
|
